Global Natural Antitumor Drug Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Natural Antitumor Drug Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Natural Antitumor Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 Taxanes
  • 1.2.3 Catharanthus Roseus
  • 1.2.4 Podophyllotoxins
  • 1.2.5 Colchicines
  • 1.2.6 Others
• 1.3 Market by Application
  • 1.3.1 Global Natural Antitumor Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Breast Cancer
  • 1.3.3 Stomach Cancer
  • 1.3.4 Ovarian Cancer
  • 1.3.5 Lung Cancer
  • 1.3.6 Testicular Cancer
  • 1.3.7 Cervical Cancer
  • 1.3.8 Endometrial Cancer
  • 1.3.9 Prostate Cancer
  • 1.3.10 Bladder Cancer
  • 1.3.11 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Natural Antitumor Drug Sales Estimates and Forecasts 2019-2030
• 2.2 Global Natural Antitumor Drug Revenue by Region
  • 2.2.1 Global Natural Antitumor Drug Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global Natural Antitumor Drug Revenue by Region (2019-2024)
  • 2.2.3 Global Natural Antitumor Drug Revenue by Region (2025-2030)
  • 2.2.4 Global Natural Antitumor Drug Revenue Market Share by Region (2019-2030)
• 2.3 Global Natural Antitumor Drug Sales Estimates and Forecasts 2019-2030
• 2.4 Global Natural Antitumor Drug Sales by Region
  • 2.4.1 Global Natural Antitumor Drug Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global Natural Antitumor Drug Sales by Region (2019-2024)
  • 2.4.3 Global Natural Antitumor Drug Sales by Region (2025-2030)
  • 2.4.4 Global Natural Antitumor Drug Sales Market Share by Region (2019-2030)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

• 3.1 Global Natural Antitumor Drug Sales by Manufacturers
  • 3.1.1 Global Natural Antitumor Drug Sales by Manufacturers (2019-2024)
  • 3.1.2 Global Natural Antitumor Drug Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Natural Antitumor Drug in 2023
• 3.2 Global Natural Antitumor Drug Revenue by Manufacturers
  • 3.2.1 Global Natural Antitumor Drug Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global Natural Antitumor Drug Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top 10 and Top 5 Companies by Natural Antitumor Drug Revenue in 2023
• 3.3 Global Key Players of Natural Antitumor Drug, Industry Ranking, 2022 VS 2023 VS 2024
• 3.4 Global Natural Antitumor Drug Sales Price by Manufacturers
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Natural Antitumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Natural Antitumor Drug, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Natural Antitumor Drug, Product Offered and Application
• 3.8 Global Key Manufacturers of Natural Antitumor Drug, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Natural Antitumor Drug Sales by Type
  • 4.1.1 Global Natural Antitumor Drug Historical Sales by Type (2019-2024)
  • 4.1.2 Global Natural Antitumor Drug Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global Natural Antitumor Drug Sales Market Share by Type (2019-2030)
• 4.2 Global Natural Antitumor Drug Revenue by Type
  • 4.2.1 Global Natural Antitumor Drug Historical Revenue by Type (2019-2024)
  • 4.2.2 Global Natural Antitumor Drug Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global Natural Antitumor Drug Revenue Market Share by Type (2019-2030)
• 4.3 Global Natural Antitumor Drug Price by Type
  • 4.3.1 Global Natural Antitumor Drug Price by Type (2019-2024)
  • 4.3.2 Global Natural Antitumor Drug Price Forecast by Type (2025-2030)

5 Market Size by Application

• 5.1 Global Natural Antitumor Drug Sales by Application
  • 5.1.1 Global Natural Antitumor Drug Historical Sales by Application (2019-2024)
  • 5.1.2 Global Natural Antitumor Drug Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global Natural Antitumor Drug Sales Market Share by Application (2019-2030)
• 5.2 Global Natural Antitumor Drug Revenue by Application
  • 5.2.1 Global Natural Antitumor Drug Historical Revenue by Application (2019-2024)
  • 5.2.2 Global Natural Antitumor Drug Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global Natural Antitumor Drug Revenue Market Share by Application (2019-2030)
• 5.3 Global Natural Antitumor Drug Price by Application
  • 5.3.1 Global Natural Antitumor Drug Price by Application (2019-2024)
  • 5.3.2 Global Natural Antitumor Drug Price Forecast by Application (2025-2030)

6 US & Canada

• 6.1 US & Canada Natural Antitumor Drug Market Size by Type
  • 6.1.1 US & Canada Natural Antitumor Drug Sales by Type (2019-2030)
  • 6.1.2 US & Canada Natural Antitumor Drug Revenue by Type (2019-2030)
• 6.2 US & Canada Natural Antitumor Drug Market Size by Application
  • 6.2.1 US & Canada Natural Antitumor Drug Sales by Application (2019-2030)
  • 6.2.2 US & Canada Natural Antitumor Drug Revenue by Application (2019-2030)
• 6.3 US & Canada Natural Antitumor Drug Market Size by Country
  • 6.3.1 US & Canada Natural Antitumor Drug Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 US & Canada Natural Antitumor Drug Sales by Country (2019-2030)
  • 6.3.3 US & Canada Natural Antitumor Drug Revenue by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Natural Antitumor Drug Market Size by Type
  • 7.1.1 Europe Natural Antitumor Drug Sales by Type (2019-2030)
  • 7.1.2 Europe Natural Antitumor Drug Revenue by Type (2019-2030)
• 7.2 Europe Natural Antitumor Drug Market Size by Application
  • 7.2.1 Europe Natural Antitumor Drug Sales by Application (2019-2030)
  • 7.2.2 Europe Natural Antitumor Drug Revenue by Application (2019-2030)
• 7.3 Europe Natural Antitumor Drug Market Size by Country
  • 7.3.1 Europe Natural Antitumor Drug Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe Natural Antitumor Drug Sales by Country (2019-2030)
  • 7.3.3 Europe Natural Antitumor Drug Revenue by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Netherlands

8 China

• 8.1 China Natural Antitumor Drug Market Size
  • 8.1.1 China Natural Antitumor Drug Sales (2019-2030)
  • 8.1.2 China Natural Antitumor Drug Revenue (2019-2030)
• 8.2 China Natural Antitumor Drug Market Size by Application
  • 8.2.1 China Natural Antitumor Drug Sales by Application (2019-2030)
  • 8.2.2 China Natural Antitumor Drug Revenue by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Natural Antitumor Drug Market Size by Type
  • 9.1.1 Asia Natural Antitumor Drug Sales by Type (2019-2030)
  • 9.1.2 Asia Natural Antitumor Drug Revenue by Type (2019-2030)
• 9.2 Asia Natural Antitumor Drug Market Size by Application
  • 9.2.1 Asia Natural Antitumor Drug Sales by Application (2019-2030)
  • 9.2.2 Asia Natural Antitumor Drug Revenue by Application (2019-2030)
• 9.3 Asia Natural Antitumor Drug Sales by Region
  • 9.3.1 Asia Natural Antitumor Drug Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia Natural Antitumor Drug Revenue by Region (2019-2030)
  • 9.3.3 Asia Natural Antitumor Drug Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Natural Antitumor Drug Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Natural Antitumor Drug Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America Natural Antitumor Drug Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America Natural Antitumor Drug Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Natural Antitumor Drug Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America Natural Antitumor Drug Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America Natural Antitumor Drug Sales by Country
  • 10.3.1 Middle East, Africa and Latin America Natural Antitumor Drug Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America Natural Antitumor Drug Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America Natural Antitumor Drug Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Company Profiles

• 11.1 Pfizer
  • 11.1.1 Pfizer Company Information
  • 11.1.2 Pfizer Overview
  • 11.1.3 Pfizer Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 Pfizer Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Pfizer Recent Developments
• 11.2 Sanofi US
  • 11.2.1 Sanofi US Company Information
  • 11.2.2 Sanofi US Overview
  • 11.2.3 Sanofi US Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 Sanofi US Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Sanofi US Recent Developments
• 11.3 Sun Pharma
  • 11.3.1 Sun Pharma Company Information
  • 11.3.2 Sun Pharma Overview
  • 11.3.3 Sun Pharma Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.3.4 Sun Pharma Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Sun Pharma Recent Developments
• 11.4 Oasmia
  • 11.4.1 Oasmia Company Information
  • 11.4.2 Oasmia Overview
  • 11.4.3 Oasmia Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.4.4 Oasmia Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Oasmia Recent Developments
• 11.5 Indena
  • 11.5.1 Indena Company Information
  • 11.5.2 Indena Overview
  • 11.5.3 Indena Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.5.4 Indena Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Indena Recent Developments
• 11.6 Bristol-Myers Squibb Company
  • 11.6.1 Bristol-Myers Squibb Company Company Information
  • 11.6.2 Bristol-Myers Squibb Company Overview
  • 11.6.3 Bristol-Myers Squibb Company Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.6.4 Bristol-Myers Squibb Company Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Bristol-Myers Squibb Company Recent Developments
• 11.7 PierreFabre
  • 11.7.1 PierreFabre Company Information
  • 11.7.2 PierreFabre Overview
  • 11.7.3 PierreFabre Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.7.4 PierreFabre Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 PierreFabre Recent Developments
• 11.8 Qilu Pharmaceutical
  • 11.8.1 Qilu Pharmaceutical Company Information
  • 11.8.2 Qilu Pharmaceutical Overview
  • 11.8.3 Qilu Pharmaceutical Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.8.4 Qilu Pharmaceutical Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Qilu Pharmaceutical Recent Developments
• 11.9 Fuxing Medicine
  • 11.9.1 Fuxing Medicine Company Information
  • 11.9.2 Fuxing Medicine Overview
  • 11.9.3 Fuxing Medicine Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.9.4 Fuxing Medicine Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Fuxing Medicine Recent Developments
• 11.10 Yuekang Pharmaceutical
  • 11.10.1 Yuekang Pharmaceutical Company Information
  • 11.10.2 Yuekang Pharmaceutical Overview
  • 11.10.3 Yuekang Pharmaceutical Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.10.4 Yuekang Pharmaceutical Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Yuekang Pharmaceutical Recent Developments
• 11.11 Hengrui Medicine
  • 11.11.1 Hengrui Medicine Company Information
  • 11.11.2 Hengrui Medicine Overview
  • 11.11.3 Hengrui Medicine Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.11.4 Hengrui Medicine Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Hengrui Medicine Recent Developments
• 11.12 Huiyu Pharmaceutical
  • 11.12.1 Huiyu Pharmaceutical Company Information
  • 11.12.2 Huiyu Pharmaceutical Overview
  • 11.12.3 Huiyu Pharmaceutical Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.12.4 Huiyu Pharmaceutical Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Huiyu Pharmaceutical Recent Developments
• 11.13 Zhendong Pharmaceutical
  • 11.13.1 Zhendong Pharmaceutical Company Information
  • 11.13.2 Zhendong Pharmaceutical Overview
  • 11.13.3 Zhendong Pharmaceutical Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.13.4 Zhendong Pharmaceutical Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 Zhendong Pharmaceutical Recent Developments
• 11.14 Chinese Academy of Sciences
  • 11.14.1 Chinese Academy of Sciences Company Information
  • 11.14.2 Chinese Academy of Sciences Overview
  • 11.14.3 Chinese Academy of Sciences Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.14.4 Chinese Academy of Sciences Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.14.5 Chinese Academy of Sciences Recent Developments
• 11.15 Hainan Changchun Pharmaceutical Co., Ltd.
  • 11.15.1 Hainan Changchun Pharmaceutical Co., Ltd. Company Information
  • 11.15.2 Hainan Changchun Pharmaceutical Co., Ltd. Overview
  • 11.15.3 Hainan Changchun Pharmaceutical Co., Ltd. Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.15.4 Hainan Changchun Pharmaceutical Co., Ltd. Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.15.5 Hainan Changchun Pharmaceutical Co., Ltd. Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Natural Antitumor Drug Industry Chain Analysis
• 12.2 Natural Antitumor Drug Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Natural Antitumor Drug Production Mode & Process
• 12.4 Natural Antitumor Drug Sales and Marketing
  • 12.4.1 Natural Antitumor Drug Sales Channels
  • 12.4.2 Natural Antitumor Drug Distributors
• 12.5 Natural Antitumor Drug Customers

13 Market Dynamics

• 13.1 Natural Antitumor Drug Industry Trends
• 13.2 Natural Antitumor Drug Market Drivers
• 13.3 Natural Antitumor Drug Market Challenges
• 13.4 Natural Antitumor Drug Market Restraints

14 Key Findings in The Global Natural Antitumor Drug Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

• Table 1. Global Natural Antitumor Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
• Table 2. Major Manufacturers of Taxanes
• Table 3. Major Manufacturers of Catharanthus Roseus
• Table 4. Major Manufacturers of Podophyllotoxins
• Table 5. Major Manufacturers of Colchicines
• Table 6. Major Manufacturers of Others
• Table 7. Global Natural Antitumor Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
• Table 8. Global Natural Antitumor Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
• Table 9. Global Natural Antitumor Drug Revenue by Region (2019-2024) & (US$ Million)
• Table 10. Global Natural Antitumor Drug Revenue by Region (2025-2030) & (US$ Million)
• Table 11. Global Natural Antitumor Drug Revenue Market Share by Region (2019-2024)
• Table 12. Global Natural Antitumor Drug Revenue Market Share by Region (2025-2030)
• Table 13. Global Natural Antitumor Drug Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
• Table 14. Global Natural Antitumor Drug Sales by Region (2019-2024) & (K Units)
• Table 15. Global Natural Antitumor Drug Sales by Region (2025-2030) & (K Units)
• Table 16. Global Natural Antitumor Drug Sales Market Share by Region (2019-2024)
• Table 17. Global Natural Antitumor Drug Sales Market Share by Region (2025-2030)
• Table 18. Global Natural Antitumor Drug Sales by Manufacturers (2019-2024) & (K Units)
• Table 19. Global Natural Antitumor Drug Sales Share by Manufacturers (2019-2024)
• Table 20. Global Natural Antitumor Drug Revenue by Manufacturers (2019-2024) & (US$ Million)
• Table 21. Global Natural Antitumor Drug Revenue Share by Manufacturers (2019-2024)
• Table 22. Global Key Players of Natural Antitumor Drug, Industry Ranking, 2022 VS 2023 VS 2024
• Table 23. Natural Antitumor Drug Price by Manufacturers 2019-2024 (US$/Unit)
• Table 24. Global Natural Antitumor Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 25. Global Natural Antitumor Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Antitumor Drug as of 2023)
• Table 26. Global Key Manufacturers of Natural Antitumor Drug, Manufacturing Base Distribution and Headquarters
• Table 27. Global Key Manufacturers of Natural Antitumor Drug, Product Offered and Application
• Table 28. Global Key Manufacturers of Natural Antitumor Drug, Date of Enter into This Industry
• Table 29. Mergers & Acquisitions, Expansion Plans
• Table 30. Global Natural Antitumor Drug Sales by Type (2019-2024) & (K Units)
• Table 31. Global Natural Antitumor Drug Sales by Type (2025-2030) & (K Units)
• Table 32. Global Natural Antitumor Drug Sales Share by Type (2019-2024)
• Table 33. Global Natural Antitumor Drug Sales Share by Type (2025-2030)
• Table 34. Global Natural Antitumor Drug Revenue by Type (2019-2024) & (US$ Million)
• Table 35. Global Natural Antitumor Drug Revenue by Type (2025-2030) & (US$ Million)
• Table 36. Global Natural Antitumor Drug Revenue Share by Type (2019-2024)
• Table 37. Global Natural Antitumor Drug Revenue Share by Type (2025-2030)
• Table 38. Natural Antitumor Drug Price by Type (2019-2024) & (US$/Unit)
• Table 39. Global Natural Antitumor Drug Price Forecast by Type (2025-2030) & (US$/Unit)
• Table 40. Global Natural Antitumor Drug Sales by Application (2019-2024) & (K Units)
• Table 41. Global Natural Antitumor Drug Sales by Application (2025-2030) & (K Units)
• Table 42. Global Natural Antitumor Drug Sales Share by Application (2019-2024)
• Table 43. Global Natural Antitumor Drug Sales Share by Application (2025-2030)
• Table 44. Global Natural Antitumor Drug Revenue by Application (2019-2024) & (US$ Million)
• Table 45. Global Natural Antitumor Drug Revenue by Application (2025-2030) & (US$ Million)
• Table 46. Global Natural Antitumor Drug Revenue Share by Application (2019-2024)
• Table 47. Global Natural Antitumor Drug Revenue Share by Application (2025-2030)
• Table 48. Natural Antitumor Drug Price by Application (2019-2024) & (US$/Unit)
• Table 49. Global Natural Antitumor Drug Price Forecast by Application (2025-2030) & (US$/Unit)
• Table 50. US & Canada Natural Antitumor Drug Sales by Type (2019-2024) & (K Units)
• Table 51. US & Canada Natural Antitumor Drug Sales by Type (2025-2030) & (K Units)
• Table 52. US & Canada Natural Antitumor Drug Revenue by Type (2019-2024) & (US$ Million)
• Table 53. US & Canada Natural Antitumor Drug Revenue by Type (2025-2030) & (US$ Million)
• Table 54. US & Canada Natural Antitumor Drug Sales by Application (2019-2024) & (K Units)
• Table 55. US & Canada Natural Antitumor Drug Sales by Application (2025-2030) & (K Units)
• Table 56. US & Canada Natural Antitumor Drug Revenue by Application (2019-2024) & (US$ Million)
• Table 57. US & Canada Natural Antitumor Drug Revenue by Application (2025-2030) & (US$ Million)
• Table 58. US & Canada Natural Antitumor Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
• Table 59. US & Canada Natural Antitumor Drug Revenue by Country (2019-2024) & (US$ Million)
• Table 60. US & Canada Natural Antitumor Drug Revenue by Country (2025-2030) & (US$ Million)
• Table 61. US & Canada Natural Antitumor Drug Sales by Country (2019-2024) & (K Units)
• Table 62. US & Canada Natural Antitumor Drug Sales by Country (2025-2030) & (K Units)
• Table 63. Europe Natural Antitumor Drug Sales by Type (2019-2024) & (K Units)
• Table 64. Europe Natural Antitumor Drug Sales by Type (2025-2030) & (K Units)
• Table 65. Europe Natural Antitumor Drug Revenue by Type (2019-2024) & (US$ Million)
• Table 66. Europe Natural Antitumor Drug Revenue by Type (2025-2030) & (US$ Million)
• Table 67. Europe Natural Antitumor Drug Sales by Application (2019-2024) & (K Units)
• Table 68. Europe Natural Antitumor Drug Sales by Application (2025-2030) & (K Units)
• Table 69. Europe Natural Antitumor Drug Revenue by Application (2019-2024) & (US$ Million)
• Table 70. Europe Natural Antitumor Drug Revenue by Application (2025-2030) & (US$ Million)
• Table 71. Europe Natural Antitumor Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
• Table 72. Europe Natural Antitumor Drug Revenue by Country (2019-2024) & (US$ Million)
• Table 73. Europe Natural Antitumor Drug Revenue by Country (2025-2030) & (US$ Million)
• Table 74. Europe Natural Antitumor Drug Sales by Country (2019-2024) & (K Units)
• Table 75. Europe Natural Antitumor Drug Sales by Country (2025-2030) & (K Units)
• Table 76. China Natural Antitumor Drug Sales by Type (2019-2024) & (K Units)
• Table 77. China Natural Antitumor Drug Sales by Type (2025-2030) & (K Units)
• Table 78. China Natural Antitumor Drug Revenue by Type (2019-2024) & (US$ Million)
• Table 79. China Natural Antitumor Drug Revenue by Type (2025-2030) & (US$ Million)
• Table 80. China Natural Antitumor Drug Sales by Application (2019-2024) & (K Units)
• Table 81. China Natural Antitumor Drug Sales by Application (2025-2030) & (K Units)
• Table 82. China Natural Antitumor Drug Revenue by Application (2019-2024) & (US$ Million)
• Table 83. China Natural Antitumor Drug Revenue by Application (2025-2030) & (US$ Million)
• Table 84. Asia Natural Antitumor Drug Sales by Type (2019-2024) & (K Units)
• Table 85. Asia Natural Antitumor Drug Sales by Type (2025-2030) & (K Units)
• Table 86. Asia Natural Antitumor Drug Revenue by Type (2019-2024) & (US$ Million)
• Table 87. Asia Natural Antitumor Drug Revenue by Type (2025-2030) & (US$ Million)
• Table 88. Asia Natural Antitumor Drug Sales by Application (2019-2024) & (K Units)
• Table 89. Asia Natural Antitumor Drug Sales by Application (2025-2030) & (K Units)
• Table 90. Asia Natural Antitumor Drug Revenue by Application (2019-2024) & (US$ Million)
• Table 91. Asia Natural Antitumor Drug Revenue by Application (2025-2030) & (US$ Million)
• Table 92. Asia Natural Antitumor Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
• Table 93. Asia Natural Antitumor Drug Revenue by Region (2019-2024) & (US$ Million)
• Table 94. Asia Natural Antitumor Drug Revenue by Region (2025-2030) & (US$ Million)
• Table 95. Asia Natural Antitumor Drug Sales by Region (2019-2024) & (K Units)
• Table 96. Asia Natural Antitumor Drug Sales by Region (2025-2030) & (K Units)
• Table 97. Middle East, Africa and Latin America Natural Antitumor Drug Sales by Type (2019-2024) & (K Units)
• Table 98. Middle East, Africa and Latin America Natural Antitumor Drug Sales by Type (2025-2030) & (K Units)
• Table 99. Middle East, Africa and Latin America Natural Antitumor Drug Revenue by Type (2019-2024) & (US$ Million)
• Table 100. Middle East, Africa and Latin America Natural Antitumor Drug Revenue by Type (2025-2030) & (US$ Million)
• Table 101. Middle East, Africa and Latin America Natural Antitumor Drug Sales by Application (2019-2024) & (K Units)
• Table 102. Middle East, Africa and Latin America Natural Antitumor Drug Sales by Application (2025-2030) & (K Units)
• Table 103. Middle East, Africa and Latin America Natural Antitumor Drug Revenue by Application (2019-2024) & (US$ Million)
• Table 104. Middle East, Africa and Latin America Natural Antitumor Drug Revenue by Application (2025-2030) & (US$ Million)
• Table 105. Middle East, Africa and Latin America Natural Antitumor Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
• Table 106. Middle East, Africa and Latin America Natural Antitumor Drug Revenue by Country (2019-2024) & (US$ Million)
• Table 107. Middle East, Africa and Latin America Natural Antitumor Drug Revenue by Country (2025-2030) & (US$ Million)
• Table 108. Middle East, Africa and Latin America Natural Antitumor Drug Sales by Country (2019-2024) & (K Units)
• Table 109. Middle East, Africa and Latin America Natural Antitumor Drug Sales by Country (2025-2030) & (K Units)
• Table 110. Pfizer Company Information
• Table 111. Pfizer Description and Major Businesses
• Table 112. Pfizer Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 113. Pfizer Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 114. Pfizer Recent Developments
• Table 115. Sanofi US Company Information
• Table 116. Sanofi US Description and Major Businesses
• Table 117. Sanofi US Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 118. Sanofi US Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 119. Sanofi US Recent Developments
• Table 120. Sun Pharma Company Information
• Table 121. Sun Pharma Description and Major Businesses
• Table 122. Sun Pharma Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 123. Sun Pharma Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 124. Sun Pharma Recent Developments
• Table 125. Oasmia Company Information
• Table 126. Oasmia Description and Major Businesses
• Table 127. Oasmia Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 128. Oasmia Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 129. Oasmia Recent Developments
• Table 130. Indena Company Information
• Table 131. Indena Description and Major Businesses
• Table 132. Indena Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 133. Indena Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 134. Indena Recent Developments
• Table 135. Bristol-Myers Squibb Company Company Information
• Table 136. Bristol-Myers Squibb Company Description and Major Businesses
• Table 137. Bristol-Myers Squibb Company Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 138. Bristol-Myers Squibb Company Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 139. Bristol-Myers Squibb Company Recent Developments
• Table 140. PierreFabre Company Information
• Table 141. PierreFabre Description and Major Businesses
• Table 142. PierreFabre Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 143. PierreFabre Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 144. PierreFabre Recent Developments
• Table 145. Qilu Pharmaceutical Company Information
• Table 146. Qilu Pharmaceutical Description and Major Businesses
• Table 147. Qilu Pharmaceutical Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 148. Qilu Pharmaceutical Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 149. Qilu Pharmaceutical Recent Developments
• Table 150. Fuxing Medicine Company Information
• Table 151. Fuxing Medicine Description and Major Businesses
• Table 152. Fuxing Medicine Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 153. Fuxing Medicine Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 154. Fuxing Medicine Recent Developments
• Table 155. Yuekang Pharmaceutical Company Information
• Table 156. Yuekang Pharmaceutical Description and Major Businesses
• Table 157. Yuekang Pharmaceutical Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 158. Yuekang Pharmaceutical Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 159. Yuekang Pharmaceutical Recent Developments
• Table 160. Hengrui Medicine Company Information
• Table 161. Hengrui Medicine Description and Major Businesses
• Table 162. Hengrui Medicine Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 163. Hengrui Medicine Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 164. Hengrui Medicine Recent Developments
• Table 165. Huiyu Pharmaceutical Company Information
• Table 166. Huiyu Pharmaceutical Description and Major Businesses
• Table 167. Huiyu Pharmaceutical Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 168. Huiyu Pharmaceutical Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 169. Huiyu Pharmaceutical Recent Developments
• Table 170. Zhendong Pharmaceutical Company Information
• Table 171. Zhendong Pharmaceutical Description and Major Businesses
• Table 172. Zhendong Pharmaceutical Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 173. Zhendong Pharmaceutical Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 174. Zhendong Pharmaceutical Recent Developments
• Table 175. Chinese Academy of Sciences Company Information
• Table 176. Chinese Academy of Sciences Description and Major Businesses
• Table 177. Chinese Academy of Sciences Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 178. Chinese Academy of Sciences Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 179. Chinese Academy of Sciences Recent Developments
• Table 180. Hainan Changchun Pharmaceutical Co., Ltd. Company Information
• Table 181. Hainan Changchun Pharmaceutical Co., Ltd. Description and Major Businesses
• Table 182. Hainan Changchun Pharmaceutical Co., Ltd. Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 183. Hainan Changchun Pharmaceutical Co., Ltd. Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
• Table 184. Hainan Changchun Pharmaceutical Co., Ltd. Recent Developments
• Table 185. Key Raw Materials Lists
• Table 186. Raw Materials Key Suppliers Lists
• Table 187. Natural Antitumor Drug Distributors List
• Table 188. Natural Antitumor Drug Customers List
• Table 189. Natural Antitumor Drug Market Trends
• Table 190. Natural Antitumor Drug Market Drivers
• Table 191. Natural Antitumor Drug Market Challenges
• Table 192. Natural Antitumor Drug Market Restraints
• Table 193. Research Programs/Design for This Report
• Table 194. Key Data Information from Secondary Sources
• Table 195. Key Data Information from Primary Sources

List of Figures

• Figure 1. Natural Antitumor Drug Product Picture
• Figure 2. Global Natural Antitumor Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
• Figure 3. Global Natural Antitumor Drug Market Share by Type in 2023 & 2030
• Figure 4. Taxanes Product Picture
• Figure 5. Catharanthus Roseus Product Picture
• Figure 6. Podophyllotoxins Product Picture
• Figure 7. Colchicines Product Picture
• Figure 8. Others Product Picture
• Figure 9. Global Natural Antitumor Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
• Figure 10. Global Natural Antitumor Drug Market Share by Application in 2023 & 2030
• Figure 11. Breast Cancer
• Figure 12. Stomach Cancer
• Figure 13. Ovarian Cancer
• Figure 14. Lung Cancer
• Figure 15. Testicular Cancer
• Figure 16. Cervical Cancer
• Figure 17. Endometrial Cancer
• Figure 18. Prostate Cancer
• Figure 19. Bladder Cancer
• Figure 20. Others
• Figure 21. Natural Antitumor Drug Report Years Considered
• Figure 22. Global Natural Antitumor Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
• Figure 23. Global Natural Antitumor Drug Revenue 2019-2030 (US$ Million)
• Figure 24. Global Natural Antitumor Drug Revenue Market Share by Region in Percentage: 2023 Versus 2030
• Figure 25. Global Natural Antitumor Drug Revenue Market Share by Region (2019-2030)
• Figure 26. Global Natural Antitumor Drug Sales 2019-2030 ((K Units)
• Figure 27. Global Natural Antitumor Drug Sales Market Share by Region (2019-2030)
• Figure 28. US & Canada Natural Antitumor Drug Sales YoY (2019-2030) & (K Units)
• Figure 29. US & Canada Natural Antitumor Drug Revenue YoY (2019-2030) & (US$ Million)
• Figure 30. Europe Natural Antitumor Drug Sales YoY (2019-2030) & (K Units)
• Figure 31. Europe Natural Antitumor Drug Revenue YoY (2019-2030) & (US$ Million)
• Figure 32. China Natural Antitumor Drug Sales YoY (2019-2030) & (K Units)
• Figure 33. China Natural Antitumor Drug Revenue YoY (2019-2030) & (US$ Million)
• Figure 34. Asia (excluding China) Natural Antitumor Drug Sales YoY (2019-2030) & (K Units)
• Figure 35. Asia (excluding China) Natural Antitumor Drug Revenue YoY (2019-2030) & (US$ Million)
• Figure 36. Middle East, Africa and Latin America Natural Antitumor Drug Sales YoY (2019-2030) & (K Units)
• Figure 37. Middle East, Africa and Latin America Natural Antitumor Drug Revenue YoY (2019-2030) & (US$ Million)
• Figure 38. The Natural Antitumor Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
• Figure 39. The Top 5 and 10 Largest Manufacturers of Natural Antitumor Drug in the World: Market Share by Natural Antitumor Drug Revenue in 2023
• Figure 40. Global Natural Antitumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
• Figure 41. Global Natural Antitumor Drug Sales Market Share by Type (2019-2030)
• Figure 42. Global Natural Antitumor Drug Revenue Market Share by Type (2019-2030)
• Figure 43. Global Natural Antitumor Drug Sales Market Share by Application (2019-2030)
• Figure 44. Global Natural Antitumor Drug Revenue Market Share by Application (2019-2030)
• Figure 45. US & Canada Natural Antitumor Drug Sales Market Share by Type (2019-2030)
• Figure 46. US & Canada Natural Antitumor Drug Revenue Market Share by Type (2019-2030)
• Figure 47. US & Canada Natural Antitumor Drug Sales Market Share by Application (2019-2030)
• Figure 48. US & Canada Natural Antitumor Drug Revenue Market Share by Application (2019-2030)
• Figure 49. US & Canada Natural Antitumor Drug Revenue Share by Country (2019-2030)
• Figure 50. US & Canada Natural Antitumor Drug Sales Share by Country (2019-2030)
• Figure 51. U.S. Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
• Figure 52. Canada Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
• Figure 53. Europe Natural Antitumor Drug Sales Market Share by Type (2019-2030)
• Figure 54. Europe Natural Antitumor Drug Revenue Market Share by Type (2019-2030)
• Figure 55. Europe Natural Antitumor Drug Sales Market Share by Application (2019-2030)
• Figure 56. Europe Natural Antitumor Drug Revenue Market Share by Application (2019-2030)
• Figure 57. Europe Natural Antitumor Drug Revenue Share by Country (2019-2030)
• Figure 58. Europe Natural Antitumor Drug Sales Share by Country (2019-2030)
• Figure 59. Germany Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
• Figure 60. France Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
• Figure 61. U.K. Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
• Figure 62. Italy Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
• Figure 63. Netherlands Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
• Figure 64. China Natural Antitumor Drug Sales Market Share by Type (2019-2030)
• Figure 65. China Natural Antitumor Drug Revenue Market Share by Type (2019-2030)
• Figure 66. China Natural Antitumor Drug Sales Market Share by Application (2019-2030)
• Figure 67. China Natural Antitumor Drug Revenue Market Share by Application (2019-2030)
• Figure 68. Asia Natural Antitumor Drug Sales Market Share by Type (2019-2030)
• Figure 69. Asia Natural Antitumor Drug Revenue Market Share by Type (2019-2030)
• Figure 70. Asia Natural Antitumor Drug Sales Market Share by Application (2019-2030)
• Figure 71. Asia Natural Antitumor Drug Revenue Market Share by Application (2019-2030)
• Figure 72. Asia Natural Antitumor Drug Revenue Share by Region (2019-2030)
• Figure 73. Asia Natural Antitumor Drug Sales Share by Region (2019-2030)
• Figure 74. Japan Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
• Figure 75. South Korea Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
• Figure 76. China Taiwan Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
• Figure 77. Southeast Asia Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
• Figure 78. India Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
• Figure 79. Middle East, Africa and Latin America Natural Antitumor Drug Sales Market Share by Type (2019-2030)
• Figure 80. Middle East, Africa and Latin America Natural Antitumor Drug Revenue Market Share by Type (2019-2030)
• Figure 81. Middle East, Africa and Latin America Natural Antitumor Drug Sales Market Share by Application (2019-2030)
• Figure 82. Middle East, Africa and Latin America Natural Antitumor Drug Revenue Market Share by Application (2019-2030)
• Figure 83. Middle East, Africa and Latin America Natural Antitumor Drug Revenue Share by Country (2019-2030)
• Figure 84. Middle East, Africa and Latin America Natural Antitumor Drug Sales Share by Country (2019-2030)
• Figure 85. Brazil Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
• Figure 86. Mexico Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
• Figure 87. Turkey Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
• Figure 88. Israel Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
• Figure 89. GCC Countries Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
• Figure 90. Natural Antitumor Drug Value Chain
• Figure 91. Natural Antitumor Drug Production Process
• Figure 92. Channels of Distribution
• Figure 93. Distributors Profiles
• Figure 94. Bottom-up and Top-down Approaches for This Report
• Figure 95. Data Triangulation
• Figure 96. Key Executives Interviewed